Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Sep;72(9):1051-8.
doi: 10.1007/s00228-016-2090-5. Epub 2016 Jul 24.

Comparative efficacy of nonhormonal drugs on menopausal hot flashes

Lujin Li  1 , Ling Xu  2 , Junyi Wu  2 , Lidan Dong  2 , Shuiyu Zhao  2 , Qingshan Zheng  3
Affiliations
Meta-Analysis

Comparative efficacy of nonhormonal drugs on menopausal hot flashes

Lujin Li et al. Eur J Clin Pharmacol. 2016 Sep.

Abstract

Purpose: The effects of nonhormonal drugs on menopausal hot flashes are still not well quantified. We therefore did a model-based meta-analysis (MBMA) to quantitate and compare the efficacy features of nonhormonal drugs on menopausal hot flashes.

Methods: Literature was searched in the public databases to extract data of clinical trials on nonhormonal drugs, including selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs), gabapentin, clonidine, and soy isoflavones. Pharmacodynamic models were used for the quantitative analysis of each drug.

Results: Thirty-nine studies were included in the analysis. The results revealed a classic pharmacodynamic maximal effect (Emax) model could describe the time course of hot-flash reduction by nonhormonal drugs. After deducting placebo effects, the Emax of SSRIs/SNRIs, gabapentin, clonidine, and soy isoflavones was 13.9 %, 14.8 %, 18.5 %, and 25.0 %, respectively. The time to achieve half of the maximal effect (ET50) of SSRIs/SNRIs, gabapentin, clonidine, and soy isoflavones was 0.18 weeks, 0 weeks, 0 weeks, and 11.6 weeks, respectively. The results showed that SSRIs/SNRIs, gabapentin, and clonidine had a rapid onset, which could reach the maximum effect immediately. However, the onset of soy isoflavones was very slow, and a duration of 16.6 weeks was needed to surpass the efficacy of paroxetine (a type of SSRIs).

Conclusions: The information provided in this study can be used as valuable supplementary information for treatment guidelines of nonhormonal drugs on menopausal hot flashes.

Keywords: Hot flashes; Menopause; Model-based meta-analysis; Nonhormonal agents.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Pharm Stat. 2012 Jul-Aug;11(4):318-24 - PubMed
    1. J Clin Epidemiol. 2006 Apr;59(4):342-53 - PubMed
    1. Clin Pharmacol Ther. 2011 Dec;90(6):828-35 - PubMed
    1. JAMA. 2007 Apr 4;297(13):1465-77 - PubMed
    1. Clin Pharmacol Ther. 2012 Sep;92(3):283-6 - PubMed

Publication types

MeSH terms

LinkOut - more resources